Nihon Kohden Corporation (JP:6849) has released an update.
Nihon Kohden Corporation has completed its acquisition of a 71.4% stake in NeuroAdvanced Corp., the parent company of Ad-Tech Medical Instrument Corporation. This strategic move consolidates the U.S. companies as subsidiaries and aligns with Nihon Kohden’s growth plans in the medical device sector. The acquisition is expected to have a minimal impact on the company’s consolidated results for FY2024.
For further insights into JP:6849 stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Bank of America Weighs in on Tesla Stock Following Trump’s Victory
- AMD or Micron: Chris Caso Selects the Superior Chip Stock to Buy
- Stock Market News Today, 11/11/24 – Stocks Close Mixed as Fed May Need Less Rate Cuts
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
